Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers.
about
Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinomaSelective loss of TGFbeta Smad-dependent signalling prevents cell cycle arrest and promotes invasion in oesophageal adenocarcinoma cell linesExtracellular proteases as targets for drug developmentPeptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.Role of Annexin-II in GI cancers: interaction with gastrins/progastrins.Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo.Tumor markers in prostate cancer I: blood-based markers.Humoral innate immune response and disease.Protumor activities of the immune response: insights in the mechanisms of immunological shift, oncotraining, and oncopromotion.Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.From plasminogen to plasmin: role of plasminogen receptors in human cancer.Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs.Correlation between metastatic potential and variants from colorectal tumor cell line HT-29.Structural Principles in the Development of Cyclic Peptidic Enzyme Inhibitors.
P2860
Q27488744-A656E8F0-B25E-4C62-88DA-8287D49492F4Q33271014-EDC05C57-B577-4CC2-897B-9D8AAD358B20Q35116202-BE1E1BD5-A3FE-4431-9D34-42EAE8878BB2Q35783096-6FA1F734-B596-4868-97F8-4DA654B3FB17Q35928337-4E402434-D0CE-4EA7-8D42-CD873E99A55FQ36485293-EBBE4DBE-9873-4547-8DC0-AD9ECBB0CC5DQ36607766-7D6ECA6D-E81A-4D3E-B3A7-B99775121491Q36623129-9DF33C7E-E0BF-4675-9BCD-F36050F16245Q36729107-6DFBDEDE-DCDE-4360-997F-456E01EA9B0DQ38132176-F16E34E3-3213-48DB-AFC6-2FDE845A4C5DQ38269342-FAF45A3E-11E9-45F7-8FBE-FD9D1041AE74Q39136980-5EAC4305-6B8C-49D8-B29E-1DCE0AE7775BQ40618623-D9BC5BC0-954B-4663-ADB3-4FE66F0497B7Q47098588-C30E5316-F3B2-4B45-ACC9-4CB2500DE16E
P2860
Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Urokinase-type plasminogen act ...... ic potential in human cancers.
@ast
Urokinase-type plasminogen act ...... ic potential in human cancers.
@en
Urokinase-type plasminogen act ...... ic potential in human cancers.
@nl
type
label
Urokinase-type plasminogen act ...... ic potential in human cancers.
@ast
Urokinase-type plasminogen act ...... ic potential in human cancers.
@en
Urokinase-type plasminogen act ...... ic potential in human cancers.
@nl
prefLabel
Urokinase-type plasminogen act ...... ic potential in human cancers.
@ast
Urokinase-type plasminogen act ...... ic potential in human cancers.
@en
Urokinase-type plasminogen act ...... ic potential in human cancers.
@nl
P1476
Urokinase-type plasminogen act ...... ic potential in human cancers.
@en
P2093
Michael J Duffy
P304
P356
10.1042/0300-5127:0300207
P577
2002-04-01T00:00:00Z